Free Trial

Curaleaf (OTCMKTS:CURLF) Shares Up 5.4% - What's Next?

Curaleaf logo with Medical background

Key Points

  • Curaleaf Holdings, Inc. shares increased by 5.4% to trade at $1.52, although trading volume decreased by 52% compared to its average daily volume.
  • The company reported a quarterly earnings per share of ($0.07), matching analysts' expectations, while facing negative margins and return on equity.
  • Curaleaf has a market capitalization of $1 billion and operates in both domestic and international cannabis markets, offering a wide range of cannabis products.
  • MarketBeat previews top five stocks to own in September.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s stock price shot up 5.4% on Monday . The company traded as high as $1.52 and last traded at $1.52. 300,634 shares traded hands during trading, a decline of 52% from the average session volume of 622,238 shares. The stock had previously closed at $1.44.

Curaleaf Price Performance

The company has a current ratio of 1.41, a quick ratio of 0.70 and a debt-to-equity ratio of 1.08. The company's fifty day moving average is $0.96 and its two-hundred day moving average is $1.04. The stock has a market cap of $954.05 million, a price-to-earnings ratio of -4.59 and a beta of 0.62.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.07) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.07). Curaleaf had a negative return on equity of 14.12% and a negative net margin of 17.37%. As a group, research analysts predict that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Read More

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines